Copy number alterations are associated with metastatic-lethal progression in prostate cancer

被引：0
|
作者：
Xiaoyu Wang
Catherine S. Grasso
Kristina M. Jordahl
Suzanne Kolb
Yaw A. Nyame
Jonathan L. Wright
Elaine A. Ostrander
Dean A. Troyer
Raymond Lance
Ziding Feng
James Y. Dai
Janet L. Stanford
机构：
[1] Fred Hutchison Cancer Research Center,Division of Public Health Sciences
[2] Cedars-Sinai Medical Center,Department of Surgery
[3] University of Washington School of Medicine,Department of Urology
[4] National Human Genome Research Institute,Cancer Genetics and Comparative Genomics Branch
[5] NIH,Departments of Pathology, Microbiology, and Molecular Cell Biology
[6] Eastern Virginia Medical School,Department of Medical Education and Clinical Sciences
[7] Elson S. Floyd School of Medicine,Department of Biostatistics
[8] Washington State University,Department of Epidemiology
[9] University of Washington School of Public Health,undefined
[10] University of Washington School of Public Health,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：494 / 506
页数：12
相关论文
共 50 条
  • [41] Copy number alterations associated with clinical features in an underrepresented population with breast cancer
    Rodrigues-Peres, Raquel M.
    Carvalho, Benilton S.
    Anurag, Meenakshi
    Lei, Jonathan T.
    Conz, Livia
    Goncalves, Rodrigo
    Cardoso Filho, Cassio
    Ramalho, Susana O. B.
    de Paiva, Geisilene R.
    Derchain, Sophie F. M.
    Lopes-Cendes, Iscia
    Ellis, Matthew J.
    Sarian, Luis O. Z.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (07):
  • [42] Sequential monitoring of single-cell copy number variation in metastatic prostate cancer
    Kuhn, Peter
    Dago, Angel E.
    Stepansky, Asya
    Carlsson, Anders
    Felch, Natalie
    Luttgen, Madelyn
    Kolatkar, Anand
    Hicks, James
    Gross, Mitcheil E.
    CANCER RESEARCH, 2013, 73 (08)
  • [43] Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression
    Liu, Wennuan
    Hou, Jun
    Petkewicz, Jacqueline
    Na, Rong
    Wang, Chi-Hsiung
    Sun, Jishan
    Gallagher, Johnie
    Bogachkov, Yedida Y.
    Swenson, Laura
    Regner, MaryAnn
    Resurreccion, W. Kyle
    Isaacs, William B.
    Brendler, Charles B.
    Crawford, Susan
    Zheng, S. Lilly
    Helfand, Brian T.
    Xu, Jianfeng
    PROSTATE, 2020, 80 (14): : 1253 - 1262
  • [44] A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer
    Zhao, Shanshan
    Leonardson, Amy
    Geybels, Milan S.
    McDaniel, Andrew S.
    Yu, Ming
    Kolb, Suzanne
    Zong, Hong
    Carter, Kelly
    Siddiqui, Javed
    Cheng, Anqi
    Wright, Jonathan L.
    Pritchard, Colin C.
    Lance, Raymond
    Troyer, Dean
    Fan, Jian-Bing
    Ostrander, Elaine A.
    Dai, James Y.
    Tomlins, Scott A.
    Feng, Ziding
    Stanford, Janet L.
    PROSTATE, 2018, 78 (14): : 1084 - 1091
  • [45] Copy number alterations and copy number variation in cancer: close encounters of the bad kind
    Speleman, F.
    Kumps, C.
    Buysse, K.
    Poppe, B.
    Menten, B.
    De Preter, K.
    CYTOGENETIC AND GENOME RESEARCH, 2008, 123 (1-4) : 176 - 182
  • [46] Identification of somatic mutations and copy number alterations in metastatic high-grade ovarian cancer
    Lee, Jung-Yun
    Yoon, Jung-Ki
    Bang, Duhee
    Song, Yong-Sang
    CANCER RESEARCH, 2014, 74 (19)
  • [47] The evolutionary history of lethal metastatic prostate cancer
    Gundem, Gunes
    Van Loo, Peter
    Kremeyer, Barbara
    Alexandrov, Ludmil B.
    Tubio, Jose M. C.
    Papaemmanuil, Elli
    Brewer, Daniel S.
    Kallio, Heini
    Hognas, Gunilla
    Annala, Math
    Kivinummi, Kati
    Goody, Victoria
    Latimer, Calli
    O'Meara, Sarah
    Dawson, Kevin J.
    Isaacs, William
    Emmert-Buck, Michael R.
    Nykter, Matti
    Foster, Christopher
    Kote-Jarai, Zsofia
    Easton, Douglas
    Whitaker, Hayley C.
    Neal, David E.
    Cooper, Colin S.
    Eeles, Rosalind A.
    Visakorpi, Tapio
    Campbell, Peter J.
    McDermott, Ultan
    Wedge, David C.
    Bova, G. S.
    CANCER RESEARCH, 2015, 75
  • [48] The evolutionary history of lethal metastatic prostate cancer
    Gunes Gundem
    Peter Van Loo
    Barbara Kremeyer
    Ludmil B. Alexandrov
    Jose M. C. Tubio
    Elli Papaemmanuil
    Daniel S. Brewer
    Heini M. L. Kallio
    Gunilla Högnäs
    Matti Annala
    Kati Kivinummi
    Victoria Goody
    Calli Latimer
    Sarah O'Meara
    Kevin J. Dawson
    William Isaacs
    Michael R. Emmert-Buck
    Matti Nykter
    Christopher Foster
    Zsofia Kote-Jarai
    Douglas Easton
    Hayley C. Whitaker
    David E. Neal
    Colin S. Cooper
    Rosalind A. Eeles
    Tapio Visakorpi
    Peter J. Campbell
    Ultan McDermott
    David C. Wedge
    G. Steven Bova
    Nature, 2015, 520 : 353 - 357
  • [49] The evolutionary history of lethal metastatic prostate cancer
    Gundem, Gunes
    Van Loo, Peter
    Kremeyer, Barbara
    Alexandrov, Ludmil B.
    Tubio, Jose M. C.
    Papaemmanuil, Elli
    Brewer, Daniel S.
    Kallio, Heini M. L.
    Hoegnas, Gunilla
    Annala, Matti
    Kivinummi, Kati
    Goody, Victoria
    Latimer, Calli
    O'Meara, Sarah
    Dawson, Kevin J.
    Isaacs, William
    Emmert-Buck, Michael R.
    Nykter, Matti
    Foster, Christopher
    Kote-Jarai, Zsofia
    Easton, Douglas
    Whitaker, Hayley C.
    Neal, David E.
    Cooper, Colin S.
    Eeles, Rosalind A.
    Visakorpi, Tapio
    Campbell, Peter J.
    McDermott, Ultan
    Wedge, David C.
    Bova, G. Steven
    NATURE, 2015, 520 (7547) : 353 - +
  • [50] Aneuploidy drives lethal progression in prostate cancer
    Stopsack, Konrad H.
    Whittaker, Charles A.
    Gerke, Travis A.
    Loda, Massimo
    Kantoff, Philip W.
    Mucci, Lorelei A.
    Amon, Angelika
    CANCER RESEARCH, 2019, 79 (13)
12345